# Helicobacter Pylori Eradication Therapy for Epileptic Children

> **NCT05297695** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sohag University** · enrollment: 126 (actual)

## Conditions studied

- Epilepsy, Generalized
- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Triple therapy for H. pylori infection

## Key facts

- **NCT ID:** NCT05297695
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-20
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-12-30
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05297695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05297695, "Helicobacter Pylori Eradication Therapy for Epileptic Children". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05297695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*